We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-10.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$501M
AUM Growth
+$25.6M
Cap. Flow
+$93.2M
Cap. Flow %
18.6%
Top 10 Hldgs %
66.14%
Holding
135
New
29
Increased
35
Reduced
10
Closed
61

Top Buys

Rank Stock Value
1
ICUI icon
ICU Medical
ICUI
+$5.87M
2
INSP icon
Inspire Medical Systems
INSP
+$5.07M
3
GH icon
Guardant Health
GH
+$4.07M
4
SIBN icon
SI-BONE Inc
SIBN
+$4.06M
5
NSTG
NanoString Technologies, Inc.
NSTG
+$3.8M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$8.34M
2
MDT icon
Medtronic
MDT
+$7.57M
3
AZTA icon
Azenta
AZTA
+$5.7M
4
CNC icon
Centene
CNC
+$5.49M
5
ZBH icon
Zimmer Biomet
ZBH
+$5.26M

Sector Composition

Rank Sector Weight
1 Healthcare 28.11%
2 Industrials 0.17%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$123M 24.54%
492,000
+277,000
+129% +$74.7M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$81.5B
$56.9M 11.36%
425,000
+200,000
+89% +$29.8M
MDT icon
3
CALL
Medtronic
MDT
$111B
$36.4M 7.26%
400,000
+300,000
+300% +$28M
FXH icon
4
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
$31M 6.19%
450,000
+350,000
+350% +$26.5M
INSP icon
5
Inspire Medical Systems
INSP
$1.5B
$15.3M 3.06%
362,673
+119,180
+49% +$5.07M
ICUI icon
6
ICU Medical
ICUI
$4.32B
$15M 2.98%
65,119
+23,800
+58% +$5.87M
ABT icon
7
CALL
Abbott
ABT
$185B
$14.5M 2.89%
200,000
+100,000
+100% +$7.03M
INCY icon
8
CALL
Incyte
INCY
$24B
$13.4M 2.67%
210,000
+200,000
+2,000% +$13M
MJ icon
9
PUT
Amplify Alternative Harvest ETF
MJ
$104M
$13M 2.6%
+43,583
New +$16.6M
XLV icon
10
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$13M 2.59%
150,000
+25,000
+20% +$2.26M
NSTG
11
DELISTED
NanoString Technologies, Inc.
NSTG
$8.84M 1.77%
596,392
+239,898
+67% +$3.8M
DXCM icon
12
DexCom
DXCM
$32.9B
$8.69M 1.73%
290,000
+107,760
+59% +$3.42M
ESTA icon
13
Establishment Labs
ESTA
$2.73B
$7.88M 1.57%
287,399
+79,517
+38% +$1.94M
SIEN
14
PUT
DELISTED
Sientra, Inc.
SIEN
$6.99M 1.4%
+55,000
New +$10.2M
AMGN icon
15
PUT
Amgen
AMGN
$204B
$6.46M 1.29%
33,200
+3,200
+11% +$624K
STAA icon
16
STAAR Surgical
STAA
$1.21B
$6.33M 1.26%
198,256
+76,700
+63% +$2.99M
LAB icon
17
Standard BioTools
LAB
$339M
$5.85M 1.17%
678,596
+453,596
+202% +$3.53M
WMGI
18
DELISTED
Wright Medical Group Inc
WMGI
$5.75M 1.15%
211,200
+34,022
+19% +$940K
XENT
19
DELISTED
Intersect ENT, Inc
XENT
$5.36M 1.07%
190,335
+106,808
+128% +$3.13M
AMRN
20
Amarin Corp
AMRN
$297M
$5.3M 1.06%
19,474
+8,224
+73% +$3M
INGN icon
21
CALL
Inogen
INGN
$182M
$4.97M 0.99%
+40,000
New +$6.59M
NSTG
22
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
$4.88M 0.97%
328,800
+253,800
+338% +$4.03M
SIBN icon
23
SI-BONE Inc
SIBN
$818M
$4.49M 0.9%
+214,684
New +$4.06M
BAX icon
24
Baxter International
BAX
$14.5B
$4.21M 0.84%
64,000
+4,000
+7% +$269K
DGX icon
25
PUT
Quest Diagnostics
DGX
$25.6B
$4.16M 0.83%
+50,000
New +$4.69M
1
2 3 4 5

Similar funds

GMP
Great Mountain Partners New Haven, Connecticut $15.1M AUM 92.9% 1-Year Est. Return
BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SRA
Summit Rock Advisors New York $16M AUM
SR
Swiss Re Zurich, Switzerland $16.4M AUM
TC
TradeLink Capital Chicago, Illinois $13.2M AUM 33.27% 1-Year Est. Return

Pura Vida Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Pura Vida Investments held 135 positions worth $501M, up 5.4% from $475M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Pura Vida Investments deployed $93.2M of net new capital in Q4 2018, opening 29 new positions and adding to 35 existing holdings. Its largest new stake was Guardant Health: 110,363 shares worth $4.15M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 35% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Boston Scientific, an estimated $8.34M trimmed.

  • Pura Vida Investments's largest Q4 2018 buy was Guardant Health: 110,363 shares worth $4.15M.
  • Pura Vida Investments added most to ICU Medical in Q4 2018, an estimated $5.87M increase.
  • Pura Vida Investments's biggest Q4 2018 reduction was Boston Scientific, cutting an estimated $8.34M.
  • Pura Vida Investments fully exited Medtronic in Q4 2018, selling an estimated $7.57M.
  • Pura Vida Investments's ten largest holdings make up 66% of its $501M portfolio in Q4 2018.
  • Pura Vida Investments opened 29 new positions and closed 61 in Q4 2018.
  • Pura Vida Investments's portfolio value rose 5.4% quarter-over-quarter to $501M.

Based on Pura Vida Investments's 13F filing for Q4 2018, filed 14 Feb 2019.